Abstract
O1-039 - Phase II Study of Amrubicin (AMR) Combined with Carboplatin (CBDCA) for Refractory Relapsed Small Cell Lung Cancer (SCLC): North Japan Lung Cancer Group 0802
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have